379 related articles for article (PubMed ID: 11812999)
21. Stress-regulated transcription factor ATF4 promotes neoplastic transformation by suppressing expression of the INK4a/ARF cell senescence factors.
Horiguchi M; Koyanagi S; Okamoto A; Suzuki SO; Matsunaga N; Ohdo S
Cancer Res; 2012 Jan; 72(2):395-401. PubMed ID: 22102693
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.
Kim YJ; Jung JK; Lee SY; Jang KL
Cancer Lett; 2010 Feb; 288(2):226-35. PubMed ID: 19656618
[TBL] [Abstract][Full Text] [Related]
23. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression.
Passegué E; Wagner EF
EMBO J; 2000 Jun; 19(12):2969-79. PubMed ID: 10856241
[TBL] [Abstract][Full Text] [Related]
24. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
25. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
26. Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: implications for cellular senescence.
Zhu D; Xu G; Ghandhi S; Hubbard K
J Cell Physiol; 2002 Oct; 193(1):19-25. PubMed ID: 12209876
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of chicken p15INK4b at senescence and in the developing brain.
Kim SH; Rowe J; Fujii H; Jones R; Schmierer B; Kong BW; Kuchler K; Foster D; Ish-Horowicz D; Peters G
J Cell Sci; 2006 Jun; 119(Pt 12):2435-43. PubMed ID: 16720639
[TBL] [Abstract][Full Text] [Related]
28. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence.
Brookes S; Rowe J; Ruas M; Llanos S; Clark PA; Lomax M; James MC; Vatcheva R; Bates S; Vousden KH; Parry D; Gruis N; Smit N; Bergman W; Peters G
EMBO J; 2002 Jun; 21(12):2936-45. PubMed ID: 12065407
[TBL] [Abstract][Full Text] [Related]
29. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
Lindström MS; Wiman KG
Oncogene; 2003 Aug; 22(32):4993-5005. PubMed ID: 12902982
[TBL] [Abstract][Full Text] [Related]
30. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
31. PPP1CA contributes to the senescence program induced by oncogenic Ras.
Castro ME; Ferrer I; Cascón A; Guijarro MV; Lleonart M; Ramón y Cajal S; Leal JF; Robledo M; Carnero A
Carcinogenesis; 2008 Mar; 29(3):491-9. PubMed ID: 18204081
[TBL] [Abstract][Full Text] [Related]
32. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts.
Wei S; Wei S; Sedivy JM
Cancer Res; 1999 Apr; 59(7):1539-43. PubMed ID: 10197626
[TBL] [Abstract][Full Text] [Related]
33. E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.
Russell JL; Weaks RL; Berton TR; Johnson DG
Oncogene; 2006 Feb; 25(6):867-76. PubMed ID: 16205640
[TBL] [Abstract][Full Text] [Related]
34. Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype.
Milyavsky M; Shats I; Erez N; Tang X; Senderovich S; Meerson A; Tabach Y; Goldfinger N; Ginsberg D; Harris CC; Rotter V
Cancer Res; 2003 Nov; 63(21):7147-57. PubMed ID: 14612508
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic down-regulation of ARF expression is a selection step in immortalization of human fibroblasts by c-Myc.
Benanti JA; Wang ML; Myers HE; Robinson KL; Grandori C; Galloway DA
Mol Cancer Res; 2007 Nov; 5(11):1181-9. PubMed ID: 17982115
[TBL] [Abstract][Full Text] [Related]
36. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
[TBL] [Abstract][Full Text] [Related]
37. Oncogenic ras and p53 cooperate to induce cellular senescence.
Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
[TBL] [Abstract][Full Text] [Related]
38. ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence.
Kodama R; Kato M; Furuta S; Ueno S; Zhang Y; Matsuno K; Yabe-Nishimura C; Tanaka E; Kamata T
Genes Cells; 2013 Jan; 18(1):32-41. PubMed ID: 23216904
[TBL] [Abstract][Full Text] [Related]
39. Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases.
Groth A; Weber JD; Willumsen BM; Sherr CJ; Roussel MF
J Biol Chem; 2000 Sep; 275(35):27473-80. PubMed ID: 10842176
[TBL] [Abstract][Full Text] [Related]
40. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence.
Sebastian T; Johnson PF
Cancer Res; 2009 Mar; 69(6):2588-98. PubMed ID: 19276382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
